Is cyclosporine indicated in HLA-identical renal transplant recipients?
Sumrani
N
N
Transplantation Division, State University of New York Health Science Center, Brooklyn 11203.
Delaney
V
V
Ding
Z
Z
Davis
R
R
Butt
K
K
Hong
J
J
D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005190:Family; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors
D003524:Cyclosporins; D006680:HLA Antigens; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone